We draw on the leadership, knowledge and expertise of our advisors who are seasoned industry executives, eminent scientists and healthcare veterans with decades of experience in leading edge science and biopharmaceutical R&D operations and commercialization.

Tadataka Yamada (Chairman) Executive Vice-President and Board Member, Takeda Pharmaceuticals and Senior Executive in Residence, Frazier Healthcare	Rudi Pauwels Venture Partner, Advent Venture Partners, London UK	Simon Campbell Former SVP, Pfizer (World-wide discovery and medicinal R&D in Europe)
Sir David Lane A*STAR Chief Scientist; Founder and former CEO of ETC	Roger Ulrich Biotech Executive & Entrepreneur	Frank Bennett Senior VP, Research, Isis Pharmaceuticals
Benjamin Seet Deputy Executive Director, A*STAR Biomedical Research Council	Bernd Wetzel Former Head of Worldwide Research and Non-clinical Development, Boehringer-Ingelheim